Cargando…
Acute portal vein thrombosis with COVID-19 and cirrhosis
• COVID-19 patients have been reported to develop thrombotic complications. • Portal vein thrombosis is known to be associated with COVID-19. • Anticoagulation in patients with a risk of bleeding needs to be carefully considered.
Autores principales: | Miyazato, Yusuke, Ishikane, Masahiro, Inada, Makoto, Ohmagari, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999790/ https://www.ncbi.nlm.nih.gov/pubmed/33816118 http://dx.doi.org/10.1016/j.idcr.2021.e01094 |
Ejemplares similares
-
Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome
por: Fujiyama, Shunichiro, et al.
Publicado: (2017) -
Portal vein thrombosis in patients with cirrhosis
por: von Köckritz, Leona, et al.
Publicado: (2017) -
Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018) -
Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
por: Yang, Hyeyoung, et al.
Publicado: (2016) -
Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)